España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Spero Therapeutics
SPRO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.19
-0.01
-0.83%
At close: -
$1.16
-0.03
-2.50%
After Hours: 7:31 PM EDT
Get Report
Comment
Spero Therapeutics (SPRO) Forecast
News
Earnings
Spero Therapeutics (SPRO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Spero Therapeutics (NASDAQ:SPRO) Stock
Spero Therapeutics Stock (NASDAQ: SPRO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 18, 2024
TD Cowen Downgrades Spero Therapeutics to Hol...
Benzinga Newsdesk
Friday, November 15, 2024
Cantor Fitzgerald Reiterates Overweight on Sp...
Benzinga Newsdesk
Thursday, November 14, 2024
Spero Therapeutics Q3 2024 GAAP EPS $(0.32) B...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights
Wednesday, November 13, 2024
Spero Therapeutics's Earnings Outlook
Benzinga Insights
Monday, November 04, 2024
HC Wainwright & Co. Maintains Buy on Spero Th...
Benzinga Newsdesk
Wednesday, October 30, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Spero Therapeutics shares are trading lower a...
Benzinga Newsdesk
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, October 29, 2024
Spero Therapeutics shares are trading lower a...
Benzinga Newsdesk
Trading Halt: Halt status updated at 4:30:00 ...
Benzinga Newsdesk
Spero Therapeutics Announces Phase 2a Proof-O...
Benzinga Newsdesk
Trading Halt: Halted at 4:00:11 p.m. ET - Tra...
Benzinga Newsdesk
Wednesday, October 16, 2024
Spero Therapeutics Presents In Vitro Data At ...
Benzinga Newsdesk
Thursday, October 03, 2024
HC Wainwright & Co. Reiterates Buy on Spero T...
Benzinga Newsdesk
Wednesday, October 02, 2024
Spero Therapeutics shares are trading higher ...
Benzinga Newsdesk
Spero Therapeutics Publishes SPR720 Phase 1 L...
Benzinga Newsdesk
Tuesday, August 06, 2024
TD Cowen Upgrades Spero Therapeutics to Buy
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Sp...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Spero T...
Benzinga Newsdesk
Monday, August 05, 2024
Spero Therapeutics shares are trading higher ...
Benzinga Newsdesk
Spero Therapeutics Q2 2024 GAAP EPS $(0.33) B...
Benzinga Newsdesk
Thursday, May 16, 2024
HC Wainwright & Co. Reiterates Buy on Spero T...
Benzinga Newsdesk
Wednesday, May 15, 2024
Spero Therapeutics Q1 2024 GAAP EPS $(0.24) M...
Benzinga Newsdesk
Thursday, April 04, 2024
Cantor Fitzgerald Reiterates Overweight on Sp...
Benzinga Newsdesk
Monday, March 18, 2024
HC Wainwright & Co. Reiterates Buy on Spero T...
Benzinga Newsdesk
Thursday, March 14, 2024
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Spero Therapeutics shares are trading higher ...
Benzinga Newsdesk
Wednesday, March 13, 2024
Recap: Spero Therapeutics Q4 Earnings
Benzinga Insights
Spero Therapeutics Q4 2023 GAAP EPS $0.96 Bea...
Benzinga Newsdesk
Earnings Scheduled For March 13, 2024
Benzinga Insights
Tuesday, March 12, 2024
Earnings Outlook For Spero Therapeutics
Benzinga Insights
Wednesday, February 28, 2024
Spero Therapeutics Announces Clearance Of IND...
Benzinga Newsdesk
Friday, January 05, 2024
Spero Therapeutics Expects To Provide Phase 2...
Benzinga Newsdesk
Tuesday, January 02, 2024
Spero Therapeutics Announces First Patient, F...
Benzinga Newsdesk
Monday, December 04, 2023
5 Value Stocks In The Healthcare Sector
Benzinga Insights
Tuesday, November 14, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Spero T...
Benzinga Newsdesk
Monday, November 13, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Recap: Spero Therapeutics Q3 Earnings
Benzinga Insights
Spero Therapeutics Q3 EPS $(0.06) Misses $(0....
Benzinga Newsdesk
Earnings Scheduled For November 13, 2023
Benzinga Insights
Friday, November 10, 2023
Earnings Outlook For Spero Therapeutics
Benzinga Insights
Wednesday, November 01, 2023
Spero Therapeutics Has Appointed Esther Rajav...
Benzinga Newsdesk
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, September 18, 2023
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
Tuesday, September 05, 2023
4 Analysts Have This to Say About Spero Therapeutics
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
